Rocky Mountain Cancer Centers is a clinical research site located in Boulder, Colorado, United States 80303.
Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers has participated in 32 clinical trials with 10 currently active.
Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive, Primary Myelofibrosis.
Sponsors: Gilead Sciences, Swedish Orphan Biovitrum, Ariad Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Colorado · View every site in Boulder
Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers has 32 clinical trials on record, with 10 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive, Primary Myelofibrosis.
Rocky Mountain Cancer Centers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.